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Abstract 
Human alpha interferons (IFN - a) cause a reor-
ganization of internal cell membranes into tubulore-
ticular inclusions (TRI). Morphogenesis and cyto-
chemistry indicate a pre-Golgi intracisternal origin 
from the endoplasmic reticulum. Clinically, TRI 
formation in human blood mononuclear cells corre-
lates with systemic IFN-a treatment or with endoge-
nous overproduction of IFN - a in viral or autoimmune 
diseases (e.g., rubella syndrome, AIDS, systemic lupus 
erythematosus). In vitro, TRI formation can be pro-
duced by treatment of Daudi lymphoblasts or vascular 
endothelial cells with IFN - a, and is blocked by actin -
omycin-D. In Daudi lymphoblasts or vascular endo-
thelial cell cultures, TRI formation parallels induction 
of 2' - 5' A synthetase, inhibition of thymidine kinase 
and growth inhibition; however , heavy water treat-
ment of Daudi cells prevented TRI formation while 
induction of 2 '-5' A synthetase and growth inhibition 
persisted. TRI formation was dissociated from IFN-a 
antiproliferative activity in a mutant clone of Daudi 
lymphoblasts. Decreased glycoprotein biosynthesis 
and increased phospholipid biosynthesis may accompa-
ny progressive TRI accumulation. 
Key words: Alpha interferon, endoplasmic reticulum, 
tubuloreticular inclusions, electron microscopy, endo-
thelium, lymphocytes, cytoskeleton, lipid chromatog-
raphy, enzyme cytochemistry, non-human primates. 
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Introduction 
Ultrastructure of TRI 
Incubation of lymphocytes, monocytes, or vascu-
lar endothelial cells with human type I interferons 
(alpha or beta) induces a characteristic change in the 
ultrastructure of pre-Golg-i cytomembranes in 
human12 ,17,21,26,46,41 , apeTB and monkey cellsll. 
The rough endoplasmic reticulum (ER) and perinucle-
ar envelope appear to be primary targets of this 
interferon effect21, but annulate lamellae and the 
transitional complex of ER - Golg-i membranes can also 
be sites of TRI formation21,\r6,46. The essential 
feature is accumulation of intracisternal membranous 
tubules which range from 22-28 nm diameter (Figs. 1, 
2). These generally have been referred to as 
"tubuloreticular" inclusions or "TRI 11 22. 
In non-human primate cells exposed to human 
alpha interferon (IFN-a), the membranous tubular 
elements often form compact, paracrystalline arrays 
within expanded cisternae of the ERll,78 (Fig. 2). 
Even before the causation of TRI by IFN-a was es-
tablished , it had been proposed that the paracrystal-
line membranous arrays in animal cells represented a 
functional variation of the loosely configured TRI 
found in human cells63, 79. This hypothesis has been 
confirmed in recent studies of rhesus monkey placen-
tal cellsll and of baboon lymphoblasts (Feldman, D, 
Grimley, PM, unpublished observations): both their-
regular tubular meshworks and the geometric para-
crystalline arrays develop in response to human IFa 
treatment (Figs. 3, 4). 
Morphogenesis of TRI 
In human cells, TRI appear to originate as mul-
tiple, branching invaginations of the membrane bilay-
ers bounding the ER or perinuclear cisternae (Fig . 1). 
The earliest tubule formation begins in the perinucle-
ar region21. In Daudi lymphoblasts very loose net-
works of intracisternal membranous tubules develop 
within 12 to 24 hours after exposure to IFN-a in 
vitro21. These networks gradually become larger and 
more compact during prolonged IFN-a stimulation, 
but the tubular branching remains irregular. Blood 
lymphocytes develop TRI within 24 hours after IFN-a 
treatment in vitro or in vivo. These are usually 
smaller and-more compact than the accumulations ob-
served in lymphoblastsl 7 but occasional "loose forms" 
are also identified. Regions of TRI developing in 
vascular endothelial cell cultures also are very small 
at initial observation; they tend to enlarge over a 
period of days12. In monkey cells, even the smallest 
regions of TRI typically exhibit a geometric 
2141 
P. M. Grimley, S. Ray , et al. 
Fig. 1. Early TRI formation intracisternal 25 nm mem -
branous tubules in Daudi lymphoblast, 12 hours after 
treatment with IFN -a ( 500 IU /m l) . Note proximity to 
perinuclear cisternum (arrow). 
Fig. 2. Typical network of TRI in a human lymphoblast 
after treatment with IFN -a (500 IU/ml) for 24 hours. 
Fig. 3. TRI in placental fibroblast of rhesus monkey fol-
low mg systematic treatment with IFN-all. Note features 
indistinguishable from the TRI in human calls. 
Fig. 4. Paracrystalline array of membranous tubules ex-
pandmg cisternum of ER in placental capillary endothelium 
of a rhesus monkey following systematic treatment with 
IFN-all. 
Fig. 5. Cytochemical reaction for acetyl cholinesterase37 
mperipheral blood lymphocyte from patient with AIDS 
and elevated serum IFN-a. Electron-dense deposits high-








Cytomembrane reorganization due to interferon 
paracrystalline configuration 11. 
Ultrastructural Cytochemistry of TRI 
Initial cytochemical digestion studies disclosed 
that TRI contain lipid and trypsin-resistant acidic 
protein components77. Nucleic acid was not detected 
by selective digestion, ion labelling, or autoradio-
graphic techniques22, 77. Additional enzyme cyto-
chemical studies now indicate that reactions for sev-
eral enzymes typically associated with the ER also 
are positive in regions of TRI (Table 1, Fig. 5), and 
suggest that ER-associated enzyme proteins must in-
sert into membranes comprising TRI during or after 
morphogenesis. 
Experimental Induction of TRI in Cell Structures 
Experimental induction of TRI has been demon-
strated in short term cultures of human peripheral 
blood lymphocytes! 7 ,47, in cultures of continuous 
lymphoblastoid cell lines (B-cell or T-cell origin), and 
in cultures of human endothelial cellsl2,51. The 
initial model for TRI induction involved treatment of 
lymphoblastoid cell cultures with halogenated 
pyrimidinesl6,24,28, and TRI formation was related to 
S-phase incorporation of BUdR28. Subsequent work 
demonstrated that the effects observed were second-
ary to induction of potent lymphoblast IFN-a70,71,86. 
Human Blood Lymphocytes 
TRI developed in short term cultures of unstim-
ulated peripheral blood lymphocytes (PBL) exposed to 
IFN-a. These included both B cells and T cells, as 
demonstrated by immunoperoxidase staining32. Blas -
togenic doses of either Concanavalin A (Con A) or 
pokeweed mitogen before IFN-a treatment increased 
the apparent size and frequency of TRI in thin sec -
tions 7,47. TRI also developed in PBL experimentally 
incubated with Staphylococcus aureus , Cowan type 
146 or with UV-inactivated Sendai virusl 7. In each 
of the latter conditions autogenous IF N-a was 
producedl7,46. 
Human Lymphoblastoid Cell Lines 
TRI have been induced in human lymphoblastoid 
cell lines of diverse origins, including lines which 
express a B-cell phenotype or a T-cell phenotype21. 
Efforts to induce TRI in the histiocytic cell line U -
9374,68 were unsuccessfu121. Initial studies with hal-
ogenated pyrimidines had demonstrated that neither 
the source of B cell (neoplastic or non-neoplastic) 
nor the burden of EB virus genomes were critical 
factors in TRI induction22. This was subsequently 
confirmed by direct IFN-a treatment of several B 
cell and T cell lines21. Recently, induction of TRI 
has been observed in two additional B-cell lines (DG-
75 and Ramos) which are free of EB virus2 ,41 and in 
a T-cell line (H-9) which carries no known retro-
viruses64. Infection of the latter with HIV -1 exerted 
no major effect on TRI formation by IFN-a 
(Orenstein J, Grimley PM, unpublished data). 
The earliest formation of TRI has been observed 
in Daudi lymphoblasts treated for 12 hours with 500 
to 1000 IU/ml of IFN-a21. In a dose range of 10 to 
1000 IU /ml of IFN-a, maximum accumulation of TRI 
occurs within 48 to 96 hours21. Differences in cell 
line sensitivity have been noted: The B cell lines 
Daudi, Raji and SB are more sensitive than Namalwa 
or BJAB, while the T cell lines HSB2 or H-9 are 
more sensitive than Molt or CCRF-CEM. The mono-
cytic line U-937 is a "non-responder 11 21, despite the 
presence of more numerous type I receptors than 
Table 1. Cytochemistry of TRI 
Selective Fixation Method Result 
Osmium-ferricyanide19 + 
KMnO4 74 + 
Selective Staining 
UAc - EDTA (RNA)77 
Ag - proteinate (glycogen) 22 
Chromic-acid PTA (mucoprotein) 77 + 




Pepsin (peptide links) 





















Sources of previous data are cited following each 
procedure. References for new experiments are cited 
under "Method". For these procedures, Daudi cells 
were treated with 300 IU /ml of IF a for 48 to 72 
hours. Approximately 5 x 10-6 Daudi cells were se-
dimented at 400 x g, washed x 1 with ice cold serum 
free medium, then fixed in ice cold 2 % glutaraldehyde 
and 1 % paraformaldehyde in O. lM sodium cacodylate 
buffer (pH 7 .2). Duration of fixation was 15 to 20 
min for localization of glucose-6-phosphatase and 5 
to 8 min for localization of guanylate cyclase or 
acetyl cholinesterase. After fixation, cells were 
rinsed x 3 in buffer and stored 4 C for up to 12 
hours. Reaction mixtures and incubation procedures 
are given in references 33-37 and 59. 
Daudi cells (Zoon, KC, personal communication). 
Lymphocytes from Non-Human Primates 
New mveshgahons have included electron 
microscopy of chimpanzee or rhesus monkey lympho-
cytes in short term cultures, and of continuous lines 
of lymphoblasts from the baboon (Papio hamadryas, 
ATCC CRL 1494, chronically infected with a herpes-
virus papio) or old world Stump tail monkey ( GM 
3442). In chimpanzee or monkey lymphocytes, IFN-a 
(500 IU /ml for 76-92 hours) induced the loose form 
of TRI12, whereas the paracrystalline forms (similar 
to type in Fig. 4) developed in the baboon and old 
world monkey cells incubated with IFN-a (100 to 
1000 IU /ml for 48-72 hours). 
Endothelial Cells 
Recent studies of early passage subcultures of 
well differentiated human endothelial cells demon-
strated induction of TRI in endothelial cells of 
venous (umbilical cord) or arterial (thoracic aorta) 
origins12. Both IFN-a12 and beta interferon51 have 
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proven active on umbilical cord venous endothelium. 
With IFN-a, TRI developed as early as after 48 hours 
of treatment and persisted for up to at least seven 
days of treatment. Apparent frequency and size of 
the TRI in thin sections generally showed a positive 
correlation both with the IFN-a concentration in a 
range of 500 to 2000 IU/ml, and the duration of ex-
posure. In contrast to findings in rhesus monkeys 
treated systemically with IFN-all, (see below), the 
TRI in human endothelial cells were never para-
crystalline. 
Current Limitations of Quantitation of TRI 
A persistent 1mped1ment to quantitative investi -
gations of TRI is the lack of discrete immunocyto-
c hemical or biochemical markers. Although the 
aggregates of TRI can measure up to 2 .5 micrometers 
maximum dimension, there is yet no discrete tech -
nique for recognizing them in the range of iight 
optical resolution. Transmission electron microscopy 
remains the only tool for definitive and quantitative 
identification. Both experimental and clinical analy -
ses therefore must rely on labor intensive thin sec -
tion counts which are subject to binomial statis-
tics18, 70. At least 200 thin sections must be exam-
ined per experimental time point to determine bino-
mially significant differences, preferably with serial 
sets of data points , as in dose effect or kinetic 
studies12,21,28, 70. 
TRI Formation During Clinical IFN-a Therapy 
Clinical trials of IFN -a therapy and pharmaco -
logic tests have provided useful materials for invest -
igating TRI formation in intac t organisms. This is 
important because an extensive body of experimental 
veterinary and clinical literature (reviewed in refer-
ence 22), previously had illustrated TRI in a variety 
of cell types and a number of experimental or dis -
ease c onditions . Viral infection appeared to be a 
major common denominator22,28,63 and the possibility 
of a relatively low molecular weight serum factor 
was suspected in the pathogenesis of TRI in congeni-
tal autoimmune disease43,5U. 
Peripheral Blood Mononuclear Cells (PBMC) 
Several series of patients with chronic viral 
infections or neoplasia have been systematically 
treated with high doses of IFN-al0,66,67. In chronic 
hepatitis type B and in hairy cell leukemia, TRI have 
been noted in circulating lymphocytes and in other 
PBMc17,26. In PBMC samples from patients with 
chronic hepatitis, immunoperoxidase studies to identi-
fy T-cells, B-cells, NK-cells and monocytes disclosed 
that TRI formed in all subsets; there appeared to be 
no preferential target populationl 7. Comprehensive 
pre-treatment and post-treatment quantitative evalua-
tions were conducted: pellets of PBMC were examined 
under standard conditions. TRI developed within 24 
hours after commencement of treatment, persisted 
and increased slightly during a two week regimen of 
therapy (up to 10% of sections), then entirely disap-
peared within 3-11 days after termination of therapy. 
Endothelial cells 
In contrast to pellets of PBMC which lend 
themselves to random thin section examination and 
statistical evaluation of morphological data, the 
variable orientation of flat endothelial cells lining 
tissue capillaries complicates quantitative analyses. 
Moreover, serial biopsies of capillary rich tissues 
such as liver or renal glomeruli may not be medically 
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indicated during IFN-a therapy. Despite these prob-
lems, TRI were detected in hepatic endothelial and 
Kupffer cells in liver biopsies from two patients 
undergoing IF N-a therapy trials80, and in endothelial 
cells of a teratoma from a patient treated with IFN-
a 72. 
Studies after recombinant human IFN-a treat-
ment of pregnant rhesus monkeys provided a unique 
opportunity to examine effects on the blood vascula -
turell: electron microscopy of placental chronic villi 
disclosed abundant TRI both in capillary endothelium 
(Fig. 4) and in the stromal Hofbauer cells and 
fibroblasts (Fig. 3); TRI were not found in control 
specimens. 
Interferon toxicity 
TRI formation in vivo may be associated with 
cytotoxic viral infectioris2J, 38; however, there has 
been no direct evidence of toxic clinical effects on 
the mononuclear or endothelial cell targets of TRI 
formationll,17. Clinical and in vitro studies of TRI 
morphogenesis also have provided no indication that 
the formation of TRI heralds cytotoxicity. TRI can 
form during active growth of lymphoblastoid cell 
cultures21 and there was no morphologic evidence of 
cytotoxicity in endothelial cell culturesl 2. 
Multiple converging profiles of endoplasmic 
reticulum develop in the hepatic cells of fetal mice 
after hepatotoxic exposure to mouse IFN-a and have 
been related to TRI56,57, but intracisternal tubular 
structures evidently do not develop. Cylindrical con-
fronting cisternae (CCC) caused by internal fusions 
of the ER3,44 ,7 5 have also been associated with clin-
ically high levels of IFN -a6 0,82, but their specificity 
and reversibility is not certain44_ Experimental con-
siderations of IFN-a and a long duration of incuba-
tion are required (1000 IU / 72 hours) to produce CCC 
in Daudi cells3. In our experience these conditions 
are irreversibly cytotoxic. In AIDS, CCC are consi-
dered an ultrastructural marker3,60,82 and occur in 
conjunction with TRI3,60,82; however , the clinical 
development of CCC is associated with terminal 
disease60. 
Experimental Modulation of TRI Formation 
Studies with metabolic inhibitors in the Daudi 
lymphoblast model have provided a few clues to 
molecular mechanisms involved in TRI morphogenesis. 
Morphogenesis is totally inhibited when actinomycin 
D is added at up to 4 hours after IFN-a and the 
frequency of TRI is reduced when actinomycin D is 
added before 12 hours21. These findings indicate 
that TRI formation depends upon new RNA transcrip-
tion. Inhibition of protein synthesis by cyclo-
heximide before 12 hours of IFN-a incubation also 
blocks TRI formation; however after 12 hours of 
IFN-a incubation, TRI formation is not significantly 
blocked by cycloheximide21. The results suggest that 
TRI morphogenesis may depend upon protein synthe-
sized earlier than 12 hours. 
Feedback inhibition of DNA replication and 
blockage of S-phase by excess thymidine88 does not 
block TRI formation; indeed, the proportion of TRI 
increased when growth of Raji lymphoblastoid cells 
was slowed by th1midine synchronization prior to ad-dition of IFN-a2 . As discussed above, halogenated 
pyrimidines (BUdR, IUdR) actually induce the forma-
tion of TRI in a number of B cell lines16,28, presum-
ably due to secondary stimulation of autogenous 
Cytomembrane reorganization due to interferon 
IFN-a production79,86. 
It was of particular interest to test experimen-
tal effects of cytoskeletal paralysis, since the cyto-
skeleton is intimately involved in membrane flow and 
translocation55 and also has been implicated in IFN-a 
signal transduction6. Poisons included deuterium 
oxide (microtubule stabilizer)49,84, colchicine orvin-
blastine (microtubule depolymerizers) 84, and cyto-
chalasin B (microfilament depolymerizer)29. For 
present studies, these were added before, with, or 
after IFN-a (Table 2). Deuterium oxide (D2O) com-
pletely blocked, and the other drugs partially inhi-
bited TRI morphogenesis. These results indicate that 
integrity of cytoskeletal system is essential for the 
TRI development in Daudi cells. Results with D2O 
are especially important, since the inhibition of TRI 
formation can thus be dissociated from some other 
biological effects of IFN-a (see below). 
Relation of TRI induction to 
Biological Effects of IFN -a 
Many medically significant biologic effects of 
IFN-a occur within 12 hours after incubation. In 
contrast, the morphogenesis of TRI does not become 
evident until 12 hours , and then only at relatively 
high concentrations of IFN -a2 1. Inhibitor studies, 
reviewed above, suggested tha t TRI morphogenesis 
depends upon a prior accumulation of structural 
proteins or of enzymes, but the exact sequence of 
pre-morphogenetic events remains uncertain. 
TRI and Anti - Viral Activity 
The effect of IF N-a on establishment of an 
antiviral state is nearly universal and not species 
restricted. The virus growth inhibition effect is 
evident as early as 4 hours after incubation 1 , 74. 
While almost all human cell lines with type 1 recep-
tors are sensitive to an antiviral effect of IFN-a, 
development of TRI is evidently not as universal: for 
example, TRI were not found in A549 human lung 
cancer cells or trisomy 21 fibrobl asts which are 
endowed with abundant type 1 receptors2 l,46, 69. 
TRI in NK effector cells 
TRI can be mduced in human NK cells. This 
was recently demonstrated by immunocytochemical 
labelling with Leu lla+ or Leu 7 antibodies31,32,34; 
however , the time scale for stimulation of NK cell 
effector functions (binding to and lysis of target 
cells) can precede TRI morphogenesis9, 62. 
Growth Inhibition and TRI 
Compared to either antiviral activity or NK 
effector modulation, growth inhibition by IF N -a is a 
relatively late effect and closely parallels TRI 
formation both in highly sensitive Daudi lymphoblas -
toid cells and endothelial cell culturesl2,~1. As 
discussed above, however, the anti-proliferative and 
morphogenic activities did not prove to be consist-
ently linked: TRI also developed (but to a lesser 
extent) in a Daudi mutant clone which selectively 
resists the an ti-proliferative activity of IF N -
a21,53,83. Conversely, we have found that treatment 
with 40% D20, which inhibits TRI morphogenesis, 
does not prevent the IFN-a antiproliferative or 2'-5' 
A synthetase induction activities (Tables 2, 3). 
Again, this demonstrated that the phenomena could 
be disassociated. Such results are not unexpected in 
view of current hypotheses which implicate multiple 
signal transduction pathways to explain the pleio-
tropic biologic actions of IFN-a13,53 after binding 
Table 2. Effect of Cytoskeletal Poisons on 
TRI Formation 
Inhibition# 





10 - 6M 
10- 6M 
40 % 
Time TRI at 
added* 48 h 
-2 h + 
0 h + 
8 h + 
0 h + 
0 h + 
-2 h 
0 h 
# All inhibitors purchased from Sigma Chemical Co. 
St. Louis, MO. D2O prepared in 10 X RPMI 1640 
(Gibco, Grand Island, NY) and diluted to appropriate 
concentration. 
*Time added after IFN-a (300 IU/ml). At this con-
centration TRI were induced in up to 10% of cell 
sections in positive controls. 
Table 3. Effects of D2O (40%) on growth and 
2 '-5' AS induction of Daudi cells 
treated with IFN-a (300 IU/ml) 
Time* 








*Time after IFN -a added. 
2'-5' AS# 
(24 h) 
7 to 11 X 
7 to 11 X 
not tested 
@compared to D2O controls at 72 h (mean of 2 
experiments at each time point). 
#specific activity of 2 '-5' A synthetase measured as 
product of 2 '-5' A /mg protein/h compared to control 
values for D2O treated or untreated cells without 
IFN -a . Methods were described previously21. Con-
trol range of 2'-5' A produced in assay: 2.6 to 4.0 
µMol/mg/h. 
to a common set of type I receptors69. 
TRI and 2 '-5' A Synthetase Induction 
Induction of 2 '-5' A synthetase is the only IFN-
a-associated phenomenon which thus far has not been 
uncoupled from TRI induction. Elevated 2 '-5' A 
synthetase was noted both in lymphoblastoid and 
endothelial cell cultures which develop TRI12,21. 
Actinomycin D and cycloheximide diminished induc-
tion of 2 '-5' A synthetase in parallel with inhibition 
of TR121. Although smooth cytomembrane prol ifera-
tions in the liver~5 and in Chinese hamster endo-
thelial cells previously have been associated with 
excess enzyme induction30,61, the 2'-5' A system is 
not membrane dependent48 and the relationship to 
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TRI remains unclear. 
Thymidine uptake 
IFN-a blocks uptake of thymidine into many cell 
types. This appears to be a direct effect on thymi-
dine kinase, rather than a consequence of growth 
inhibition14. We have recently observed a similar 
effect on amino acid and galactose transport into 
Daudi cells after 12-24 hours incubation in IFN-a, 
100 IU/ml (Rupp, B, Grimley, PM, unpublished data). 
These phenomena probably are independent of TRI 
formation. Feedback inhibition of DNA biosynthesis 
by excess thymidine88 also had no effect on TRI 
morphogenesis in Daudi cells. 
Correlations of TRI Morphogenesis with 
Effects on Macromolecular Metabolism 
P:i·otein biosy nthesis 
Studies of lymphoblasts treated with BUdR 
indicated a shift in protein biosynthesis during TRI 
formation 71 Gel electrophoretic analysis of hairy 
leukemic cells which develop TRI after IFN-a treat-
ment have shown induction of up to 16 proteins75,76. 
Similar results have been reported with Daudi cells 
after IFN-a treatment53. Enzyme cytochemical 
data79 indicate that TRI membranes are associated 
with protein; however, the specificity and relation to 
induction of specific proteins by IF N-a remains to be 
determined. 
Glycoprotein biosynthesis 
Formation of massive TRI in the ER raises 
questions regarding their possible functional effect 
on cytosecretory activities. A role of TRI in immu-
noglobulin secretion was formerly postulated87, but 
would not explain the development of TRI in T cells 
or endothelium. Daudi lymphoblastoid cells which 
form abundant TRI also secrete IgM40; and they are 
a promising model for testing effects of TRI on the 
cytosecretory process. It has been shown that bio-
synthesis of IgM in Daudi cells diminishes during 
IFN-a treatment27, but an effect of TRI morpho-
genesis on glycoprotein translocation through the 
Golgi73 was not thereby excluded. In preliminary 
studies, we have observed a reduction of total eel -
lular IgM in extracts of Daudi cells treated for 24 or 
48 hours with IFN - a (Fig. 6). At up to 24 hours, we 
could discern no general effect of IF N -a on the 
pattern of glycoprotein biosynthesis in extracts of 
cells analyzed by gradient gel electrophoresis after 
labelling with 3H-galactose (Fig. 7). After 24 hours, 
uptake of 3H-galactose was almost totally blocked 
(Fig. 7); but Western blots for total IgM (Fig. 6) 
failed to suggest any correlation of TRI with 
accumulation of unlabelled glycoprotein. This is 
consistent with immunofluorescence evidence of slgM 
down -regulation81. 
Lipid Bio syn thesis 
The role of lipids in TRI appears self-evident 
from ultrastructural and cytochemical evidence. The 
preservation of TRI membranes after KMn04 oxida-
tion is particularly striking (Fig. 8) and favors the 
concept of a phospholipid core structure77. In neo-
natal mice treated with interferon, there was a 
marked increase in hepatic triglycerides accompanied 
by a decrease in phospholipids89, and this may be 
the counterpart of morphologic changes in the endo-
plasmic reticulum (see references 56, 57). Using 
Daudi cells treated with IFN-a, we found that total 
uptake of 3H-glycerol is not decreased by IFN-a. 
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This contrasted to the diminished uptake of 3H-TdR, 
3H-galactose and 3H-amino acids (see above). Pre-
liminary results of lipid extractions and high resolu -
tion thin layer chromatography58 further indicated 
that specific incorporation of 3H-glycerol into 
phosphatidyl choline increases two-fold between 46-
54 hours, at a time when TRI are accumulating 
(Table 4). 
Table 4. Thin layer chromatographic analysis of 
Daud1 cells labelled with 3H-glycerol * at 46-54 hours 
Treatment 
None 
!Fa 100 IU/ml# 
!Fa 1000 IU /ml# 
3mM TdR 
CPM/mg dry Phosphatidyl Choline 










#mtrapure leukocyte interferon (Interferon Sciences, 
New Brunswick, NJ). 
*specific activity 33.7Ci/mM, concentration 5 µCi/ml 
* *Pellet desiccated prior to extraction by Harth 
method (58) 
@Phospholipid bands identified by molybdenum blue 
staining and quantitated by scanning densitometry 
(58) . Radioactivity counted after scraping of bands 
into organic scintillation fluid. 
Clinical Pathogenesis of TRI 
Despite the technical demands of TRI quantita-
tion in ultra thin sections, detection of TRI in peri-
pheral blood mononuclear cells has proven to be a 
valid clinical parameter in evaluating groups of pa-
tients with persistently abnormal endogenous eleva-
tions of serum IFN-a (e.g., AIDS, systemic lupus ery -
thematosus)19,20,42,60. In AIDS, appearance of TRI 
correlates strongly with disease progression, re due -
tion in T4 cells and production of endogenous acid-
labile IFN-a19,20,60,65. In systemic lupus erythe-
matosus, both prospective and retrospective analysis 
have disclosed a positive correlation of TRI form a -
tion with abnormal serum levels of IFN-al9,42. 
Disseminated TRI are most frequent in diseases 
with high levels of endogenous interferon produc-
tion44, 4"5; however, TRI have also been observed in a 
number of other conditions, without measurable levels 
of serum IFN-a85. Mechanisms for pathogenesis of 
TRI probably include virus infections with localized 
paracrine or autocrine IFa production7-9,54. TRI are 
common in fetuses from gestations complicated by 
rubella infection38, and may be associated with in-
terferonogenic togavirus infections under experimen -
tal conditions15. Cells chronically infected with 
HIV-1 may induce formation of the acid labile alpha 
interferon prevalent in AIDS5. A role of endotoxin 
in stimulation of autogenous interferon production 
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Fig. 6. Western blot for IgM. Cells were extracted 
with 0. 5 % Nonidet P-40 buffer and 2 mg of protein 
were applied to each 0. 5 cm lane on a 6-12 % SD S 
gradient gel for electrophoresis. A nitrocellulose 
blot was blocked with milk reagent, then reacted 
with biotinylated goat polyclonal anti-IgM, and 
developed with the Vector ABC method. Lanes 1 and 
4: Daudi control cells at 24 and 48 hours. Lanes 2 
and 5: Dau di cells treated with 500 IU /ml of IF N-a 
for 24 and 48 hours. Lanes 3 and 6: H-9 (T-cell) 
control cells at 24 and 48 hours. 
Fig. 7. SDS 6-12% gradient gel electrophoresis of 
Daud1 cells stabilized in Laemmeli buffer after 8 
hours labelling with 3H-galactose at 46 hours (lane 1 
- 4) or 16 hours (lane 5 - 8). Control samples 
(lanes 2, 6) and samples treated with 3mM thymidine 
to inhibit growth (lanes 1, 5) were compared with 
samples treated with IFN-a 100 IU/ml (lanes 3, 7) or 
IFN-a 1000 IU/ml (Lanes 4, 8). 
was recently demonstrated in NK cells and associated 
with TRI formation48. Thus, the development of TRI 
in human blood cells or solid tissues in infections, 
auto-immune diseases and neoplasias may be stimu-
lated by a wide variety of pathogenetic events rre-
disposing to local increases of interferon 7, 39, 5 . 
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Discussion with Reviewers 
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H. Gamliel: Using immunoelectron microscopy we re-
corded changes in membrane antigens and receptors 
of Daudi cells as early as 2 h after incubation with 
1000 U/ml of IFN-a (see Gamliel H, Gurfel D, Wu 
SH, Golomb HM, Interferon induced alterations in 
hairy cells - a review, Scanning Microsc 2: 485-492, 
1988). You state that TRI are detected only after 12 
hours. It might be that these two types of types of 
changes are totally unrelated, but could you exclude 
the possibility that TRI are seen later because they 
are not induced by IFN-a itself, but rather by some 
other factor existing in the cultures. Did you use 
gamma interferon, B-cell growth factor, anti-lFN-a 
or other controls to prove that TRI are directly 
induced by IFN-a? 
Authors: This raises an important, but complex 
question. We previously learned that the delayed, S-
phase effect of halogenated pyrimidines on TRI in -
duction28 was actually due to a secondary stimulation 
of interferon production in the cultures86. Thus, it 
is perfectly logical to inquire whether the delayed 
effect of IF N -a itself reflects just another level in a 
cascade of growth factors leading to TRI formation. 
In our view, a cascade of subcellular biochemical 
events (such as induction of 2'-5' A synthetase) 
probably does precede TRI formation and account for 
the delay in their morphogenesis, but this is not evi-
dently due to the "feedback" and production of other 
extracellular bioregulators such as gamma interferon. 
This conclusion is based upon experimental induction 
Cytomembrane reorganization due to interferon 
of TRI in T-cells and endothelial cells which have 
different growth factor binding affinities and sensi-
tivities as compared to B-cells, and also upon failure 
thus far to induce TRI with gamma interferon or 
with IL-2, either directly or indirectly, by exposure 
of lymphocytes to lectinsl 7. Interestingly, beta-
interferon, which shares type I receptors with IFN-a, 
does induce TRI. With regard to specificity, we have 
used pure recombinant forms of IFN-a and blocked 
-TRI induction with actinomycin D (this indicates 
involvement of new mRNA transcription). 
H. Gamliel: Studying TRI by means of transmission 
electron microscopy bears the disadvantage of 
screening only a thin slice of each cell. In hairy 
cell leukemia we were unable to correctly determine 
the percentages of cells displaying TRI formation. 
Besides time-consuming serial sectioning, are there 
other methods available for quantitating TRI in mixed 
cell population? 
Authors: A simpler method for quantitation of TRI 
or component product has been a major objective of 
our research, but we have thus far found no specific 
radiolabel, immunolabel, or stain which can be detec-
ted by light optics. Conventional tissue processing 
for light microscopy is unsatisfactory, since lipids 
are extracted during embedding. Fixation of cells 
with KMnO4 offers a useful alternative for elec tron 
microscopic screening, since the TRI are thus high-
lighted (Fig. 8); but the counting of thin sections is 
still tedious. Incidentally, we prefer step rather 
than serial sections, since the significance of differ -
ences in TRI counts is a binomial statistic. Based 
upon the assumption of round cells , we previously 
estimated broad ranges for significant differences in 
TRI counts when at least 200 random thin sections 
of separate cells were counted28. TRI counts of se-
rial samples or multiple patient samples have been 
successfully correlated with clinical data in double 
blind studies20,42,60, and there have been good cor-
relations in studies of IFN-a therapyl 7, 26. Despite 
these results, we agree that development of a more 
sensitive, quantitative detection method would be 
more practical and more widely applicable in clinical 
diagnosis, follow-up of disease progression or 
evaluation of therapies. 
A. Hiraoka: The authors and their colleagues 
suggested that TRI contain an acidic protein compo-
nent77, and inhibitor tests indicated that TRI forma-
tion depends upon protein synthesis21. Among the 
numerous complex changes induced by interferon 
treatment, overall inhibition of protein synthesis and 
increased synthesis of a specific group of proteins 
has been noted. An analysis of protein synthesis and 
patterns during TRI formation might aid in biochemi-
cal identification of TRI components. Have you ever 
studied this relationship? 
Authors: This is essential work which needs to be 
pursued. As you point out, up to 16 induced pro-
teins have been detected in extracts of leukemic 
cells after IFN-a treatment53,75,76_ In patients with 
hairy cell leukemia, protein induction by IFN-a can 
continue for many days76 and parallel the increase 
of TRI (Hiraoka A, Rosner MC, Golomb HM, In vitro 
response of cells from three patients with haTry cell 
leukemia to a recombinant leukocyte interferon. 
Virchows Arch. [Bl 49: 73-82, 1985). One approach 
might be to compare patterns of protein induction in 
different cell lines which respond to interferon, but 
only some of which produce TRI. Another approach 
would be to analyze cell fractions. We have begun 
some preliminary tests, but our main emphasis re-
cently has been on the lipid studies. 
J. Moss: The effect of interferon on lipid biosynthe-
sis and thus membrane integrity does seem to contri-
bute to the formation of endoplasmic reticulum ab-
normalities. It has been suggested that the inter-
feron-induced tubular aggregates seen in neonatal 
mice are the morphologic counterparts of biochemical 
abnormalities of lipid biosynthesis56. 
Authors: We certainly agree with this point; how-
ever, m contrast to the results from experimental 
studies of suckling mice89; our data suggests that 
TRI in Daudi cells may be associated with increased 
phospholipid biosynthesis. As with CCC (see below), 
there may be more than one ER membrane abnormal -
ity induced by IFN-a, perhaps depending on dose, 
duration, or species. 
H. Gamliel: You mention that in AIDS, CCC occur in 
conjunction with TRI. Are the CCC linked physically 
to TRI or do they just occur in the same cell with 
no structural connections? 
Authors : CCC represent abnormal cylindrical forma-
tions of the ER which appear to result from pro-
longed or excessive IFN-a exposure3,44. In AIDS, 
CCC appear later than TRI and suggest a poor prog-
nosis (Orenstein JM, Preble OT, Kind P, Schulof R. 
The relationship of serum alpha-interferon and ultra-
structural markers in HIV-seropositive individuals. 
Ul trastruct. Pathol. 11: 673-679, 1987). Ultrastruc -
turally, TRI and CCC sometimes form in the same 
cells44, and they can be entrapped within CCC, 
presumably because they bc,th arise from the ER 
(Kostianovsky M, ::ang Y-H, Grimley PM. Ultra-
structural and immunoelectron microscopic studies of 
cells with abnormal cytoplasmic inclusions in patients 
with AIDS. AIDS Res. 1: 181-196 , 1984). 
H. Gamliel: The paracrystalline structures you men-
tion are quite different from the "classical" TRI. 
Why are they placed in the same category? The fact 
that both develop in response to human IFN-a treat-
ment does not necessarily prove them to be identical 
entities. 
Authors: We long suspected a similarity of "classi-
cal" TRI and the paracrystalline or "geometric" TRI 
and hypothesized a difference in tubule packing; the 
tubule diameters are similar22,79. It is now evident 
that both types of structures are induced by IFN-a; 
however, only the "classical" form occurs in human 
tissues. In the rhesus monkey, both forms of TRI 
were observed after systemic IFN-a treatmentll and 
this appeared to depend upon cell type (classical 
form only in endothelium, paracrystalline forms in 
fibroblasts and syncytial trophoblasts). Work in 
progress (D. Feldman and P. Grimley, unpublished) 
shows that both forms may be induced in lymphoblast 
cultures of subhuman primate origin. We agree that 
such observations "beg the question" until a biochem-
ical proof of identity becomes available. As in many 
other morphologic studies, our interpretations are 
based upon good circumstantial evidence. 
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